95 related articles for article (PubMed ID: 7816386)
1. A novel method for labelling human immunoglobulin-G with 99Tcm suitable for inflammation scintigraphy.
Mishra P; Singh AK; Chauhan M; Bhatnagar A; Kashyap R; Chauhan UP
Nucl Med Commun; 1994 Sep; 15(9):723-9. PubMed ID: 7816386
[TBL] [Abstract][Full Text] [Related]
2. A simplified kit for instant preparation of technetium-99m human immunoglobulin-G for imaging inflammatory foci.
Singh AK; Mishra P; Kashyap R; Chauhan UP
Nucl Med Biol; 1994 Feb; 21(2):277-81. PubMed ID: 9234294
[TBL] [Abstract][Full Text] [Related]
3. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
4. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
5. A kit for the instant preparation of 99Tcm-citrate for tumour and inflammation scintigraphy.
Chauhan UP; Mishra P; Chuttani K; Bhatnagar A; Bal CS
Nucl Med Commun; 1996 Nov; 17(11):979-85. PubMed ID: 8971871
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations.
Claessens RA; Boerman OC; Koenders EB; Oyen WJ; van der Meer JW; Corstens FH
Eur J Nucl Med; 1996 Apr; 23(4):414-21. PubMed ID: 8612662
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of sterically stabilized liposomes as a vehicle for targeting technetium-99m labelled radiopharmaceuticals.
Kumar S; Singh T; Khar RK; Sharma SN; Chauhan UP
Pharmazie; 1993 Aug; 48(8):613-6. PubMed ID: 8415859
[TBL] [Abstract][Full Text] [Related]
8. 99Tcm-p-aminohippuric acid as a new renal agent.
Djokić D; Janković D; Maksin T; Jaksić E; Beatović S; Han R
Nucl Med Commun; 1999 Dec; 20(12):1133-40. PubMed ID: 10664994
[TBL] [Abstract][Full Text] [Related]
9. A new method for radiolabeling of human immunoglobulin-G and its biological evaluation.
Singh T; Kumar N; Soni S; Rawat H; Mittal G; Singh AK; Bhatnagar A
J Pharm Bioallied Sci; 2012 Oct; 4(4):286-90. PubMed ID: 23248561
[TBL] [Abstract][Full Text] [Related]
10. Radiolabelling leukocytes with 99Tcm-stannous chloride colloid for the detection of inflammatory lesions.
Yu CC; Tow DE; Ahn CS; Syravanh C
Nucl Med Commun; 1997 Jan; 18(1):70-4. PubMed ID: 9061705
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
Hazari PP; Shukla G; Goel V; Chuttani K; Kumar N; Sharma R; Mishra AK
Bioconjug Chem; 2010 Feb; 21(2):229-39. PubMed ID: 20108938
[TBL] [Abstract][Full Text] [Related]
12. Retention of technetium-99m in infectious foci in rats after release from technetium-99m labelled human non-specific polyclonal immunoglobulin G: a dual-label study with hydrazinonicotinamido and iminothiolano immunoglobulin.
Claessens RA; Koenders EB; Oyen WJ; Corstens FH
Eur J Nucl Med; 1996 Nov; 23(11):1536-9. PubMed ID: 8854855
[TBL] [Abstract][Full Text] [Related]
13. Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine.
Ahlgren S; Andersson K; Tolmachev V
Nucl Med Biol; 2010 Jul; 37(5):539-46. PubMed ID: 20610158
[TBL] [Abstract][Full Text] [Related]
14. Preparation and properties of 99Tcm-exametazime using stannous ion augmentation of fractionated cold kits.
Baker RJ
Nucl Med Commun; 1999 Mar; 20(3):287-93. PubMed ID: 10093080
[TBL] [Abstract][Full Text] [Related]
15. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three remote radiolabelling methods for long-circulating liposomes.
van der Geest T; Laverman P; Gerrits D; Franssen GM; Metselaar JM; Storm G; Boerman OC
J Control Release; 2015 Dec; 220(Pt A):239-244. PubMed ID: 26514291
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 99Tcm-labelled human immunoglobulin in animal models of experimentally induced inflammatory lesions.
Shimpi HH; Noronha OP; Samuel AM
Nucl Med Commun; 1995 Oct; 16(10):846-52. PubMed ID: 8570115
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
Mukherjee A; Kothari K; Tóth G; Szemenyei E; Sarma HD; Környei J; Venkatesh M
Nucl Med Biol; 2006 Jul; 33(5):635-43. PubMed ID: 16843838
[TBL] [Abstract][Full Text] [Related]
20. The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.
Mardirossian G; Wu C; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 1992 Jul; 13(7):503-12. PubMed ID: 1495677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
